Other
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Abstract
No abstract.
Paper Details
Title
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Published Date
Sep 8, 2021
Journal
Volume
139
Issue
7
Pages
1026 - 1038